Thrombolytic Therapy for Central Retinal Artery Occlusion in an Academic Multi-Site Stroke Centre

References

• Lee KE, Tschoe C, Coffman SA, et al. Management of acute central retinal artery occlusion, a “retinal stroke”: an institutional series and literature review. J Stroke Cerebrovasc Dis. 2021;30(2):105531. doi:10.1016/j.jstrokecerebrovasdis.2020.105531.
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: a scientific statement from the American heart association. Stroke. 2021;52(6):e282–e294. doi:10.1161/STR.0000000000000366.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca.
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Lavin P, Kirshner H, Schrag M. Thrombolytic therapy for acute central retinal artery occlusion. Stroke. 2020;51(2):687–695. doi:10.1161/STROKEAHA.119.027478.
   PubMed Web of Science ®Google Scholar
• Raber FP, Gmeiner FV, Dreyhaupt J, et al. Thrombolysis in central retinal artery occlusion: a retrospective observational study. J Neurol. 2023;270(2):891–897. doi:10.1007/s00415-022-11439-7.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Dattilo M, Newman NJ, Biousse V. Treatment of nonarteritic acute central retinal artery occlusion. Asia Pac J Ophthalmol (Phila). 2018;7(4):235–241. doi:10.22608/APO.201871.
   PubMed Web of Science ®Google Scholar
• Hakim N, Hakim J. Intra-arterial thrombolysis for central retinal artery occlusion. Clin Ophthalmol. 2019;13:2489–2509. doi:10.2147/OPTH.S232560.
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal and ophthalmic artery occlusions preferred practice pattern®. Ophthalmology. 2020;127(2):259–P287. doi:10.1016/j.ophtha.2019.09.028.
   PubMed Web of Science ®Google Scholar
• Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol. 2015;72(10):1148–1154. doi:10.1001/jamaneurol.2015.1578.
   PubMed Web of Science ®Google Scholar
• Cronin CA, Sheth KN, Zhao X, et al. Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke. Stroke. 2014;45(9):2745–2749. doi:10.1161/STROKEAHA.114.005443.
   PubMed Web of Science ®Google Scholar
• Shahjouei S, Bavarsad Shahripour R, Dumitrascu OM. Thrombolysis for central retinal artery occlusion: an individual participant-level meta-analysis. Int J Stroke. 2023; 17474930231189352. doi:10.1177/17474930231189352.
   Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211.
   PubMed Web of Science ®Google Scholar
• Dorner GT, Polska E, Garhofer G, Zawinka C, Frank B, Schmetterer L. Calculation of the diameter of the central retinal artery from noninvasive measurements in humans. Curr Eye Res. 2002;25(6):341–345. doi:10.1076/ceyr.25.6.341.14231.
   PubMed Web of Science ®Google Scholar
• Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol. 2020;40(3):333–345. doi:10.1097/WNO.0000000000001027.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang Y, Zhang R. Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2023;261(1):103–113. doi:10.1007/s00417-022-05797-1.
   PubMed Web of Science ®Google Scholar
• Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol. 2008;146(5):700–6. doi:10.1016/j.ajo.2008.06.016.
   PubMed Web of Science ®Google Scholar
• Preterre C, Godeneche G, Vandamme X, et al. Management of acute central retinal artery occlusion: intravenous thrombolysis is feasible and safe. Int J Stroke. 2017;12(7):720–723. doi:10.1177/1747493016687578.
   PubMed Web of Science ®Google Scholar
• Nedelmann M, Graef M, Weinand F, et al. Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion. Stroke. 2015;46(8):2322–2324. doi:10.1161/STROKEAHA.115.009839.
   PubMed Web of Science ®Google Scholar
• Schultheiss M, Hartig F, Spitzer MS, et al. Intravenous thrombolysis in acute central retinal artery occlusion - a prospective interventional case series. PLoS One. 2018;13(5):e0198114. doi:10.1371/journal.pone.0198114.
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Nackenoff A, Poli S, et al. Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke. 2020;51(7):2018–2025. doi:10.1161/STROKEAHA.119.028743.
   PubMed Web of Science ®Google Scholar
• Zivin JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol. 2009;66(1):6–10. doi:10.1002/ana.21750.
   PubMed Web of Science ®Google Scholar
• Chodnicki KD, Tanke LB, Pulido JS, et al. Stroke risk before and after central retinal artery occlusion: a population-based analysis. Ophthalmology. 2022;129(2):203–208. doi:10.1016/j.ophtha.2021.07.017.
   PubMed Web of Science ®Google Scholar
• Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the freiburg visual acuity test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142. doi:10.1007/s00417-008-0926-0.
   PubMed Web of Science ®Google Scholar
• Hoyer C, Kahlert C, Guney R, Schlichtenbrede F, Platten M, Szabo K. Central retinal artery occlusion as a neuro-ophthalmological emergency: the need to raise public awareness. Eur J Neurol. 2021;28(6):2111–2114. doi:10.1111/ene.14735.
   PubMed Web of Science ®Google Scholar
• Chan W, Flowers AM, Meyer BI, Bruce BB, Newman NJ, Biousse V. Acute central retinal artery occlusion seen within 24 hours at a tertiary institution. J Stroke Cerebrovasc Dis. 2021;30(9):105988. doi:10.1016/j.jstrokecerebrovasdis.2021.105988.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao X, Xu F, et al. A systematic review and meta-analysis comparing FAST and BEFAST in acute stroke patients. Front Neurol. 2021;12:765069. doi:10.3389/fneur.2021.765069.
   PubMedGoogle Scholar
• Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92(5):588–593. doi:10.1136/bjo.2007.133488.
   PubMed Web of Science ®Google Scholar
• Sobol EK, Sakai Y, Wheelwright D, et al. Intra-arterial tissue plasminogen activator for central retinal artery occlusion. Clin Ophthalmol. 2021;15:601–608. doi:10.2147/OPTH.S272126.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140(3):376–91. doi:10.1016/j.ajo.2005.03.038.
   PubMed Web of Science ®Google Scholar
• Chen CS, Lee AW, Campbell B, et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke. 2011;42(8):2229–2234. doi:10.1161/STROKEAHA.111.613653.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2017;48(12):e343–e361. doi:10.1161/STR.0000000000000152.
   PubMed Web of Science ®Google Scholar
• Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010;117(7):1367–75 e1. doi:10.1016/j.ophtha.2010.03.061.
   PubMed Web of Science ®Google Scholar
• Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology. 1999;106(4):768–73. doi:10.1016/S0161-6420(99)90165-3.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang Y, Zhang R. Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. J Neurol. 2022;269(4):1825–1833. doi:10.1007/s00415-021-10838-6.
   PubMed Web of Science ®Google Scholar
• Dumitrascu OM, English S, Alhayek N, et al. Telemedicine for acute monocular visual loss: a retrospective large telestroke network experience. Telemed J E Health. 2023;29(11):1738–1743. doi:10.1089/tmj.2022.0286.
   PubMed Web of Science ®Google Scholar
• English SW, Barrett KM, Freeman WD, Demaerschalk BM, Dumitrascu OM. Improving the telemedicine evaluation of patients with acute vision loss: a call to eyes. Neurology. 2022;99(9):381–386. doi:10.1212/WNL.0000000000200969.
   PubMed Web of Science ®Google Scholar
• Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378(17):1573–1582. doi:10.1056/NEJMoa1716405.
   PubMed Web of Science ®Google Scholar
• Gao L, Parsons M, Churilov L, et al. Cost-effectiveness of tenecteplase versus alteplase for stroke thrombolysis evaluation trial in the ambulance. Eur Stroke J. 2023;8(2):448–455. doi:10.1177/23969873231165086.
   PubMed Web of Science ®Google Scholar
• Hanna E, Barrett TW. Tenecteplase to replace alteplase? Comparing thrombolytic therapies for acute ischemic stroke: June 2023 annals of Emergency Medicine Journal Club. Ann Emerg Med. 2023;81(6):759–760. doi:10.1016/j.annemergmed.2023.04.012.
   PubMed Web of Science ®Google Scholar
• Miller SE, Warach SJ. Evolving thrombolytics: from alteplase to Tenecteplase. Neurotherapeutics. 2023;20(3):664–678. doi:10.1007/s13311-023-01391-3.
   PubMed Web of Science ®Google Scholar